Canada’s Top 40 Under 40 Honoree
2018
Associate Professor, Dept of Pharmacology & Toxicology & Scientific Director at mitoNET
University of Toronto & The Canada Mitochondrial Network
Dr. Ana Andreazza is an Associate Professor in the Departments of Pharmacology & Toxicology and Psychiatry at University of Toronto and holds a Tier II Canada Research Chair in Molecular Pharmacology of Mood Disorders. She is the Research Scientific Director of The Canada Mitochondrial Network – www.mitoNET.ca, an Advisor for the Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital, a consultant for the Bipolar Biobank at Mayo Clinic, and a member of the Board of Directors at the International Society of Bipolar Disorder. Ana’s research focuses on understanding the role of mitochondrial function in mental illness, especially in mood disorders. As neurons depend on mitochondrial function, dysfunctional mitochondria during neurodevelopment is expected to impact neurotransmission with potentially crucial implications for mood disorders. Currently, Ana is evaluating the impact of mitochondrial dysfunction on neurotransmission using 2D and 3D systems generated from induced pluripotent stem cells from patients with bipolar disorder and
Please note: Company names and biographical information here may reflect the role and activity held at the time of receiving the award.
